ArticleMolecular therapy. Methods & clinical development2020

Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies.

Ceren Tuzmen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.